Through The Cords

Executive Summary

Through The Cords (TTC) is a San Diego-based medical device company addressing the critical safety challenges of intubation, the third most common medical procedure in the U.S. with over 30 million performed annually. The company's flagship product, the Runnels Steerable Introducer™, is designed to simplify and secure airway management, particularly when used in conjunction with video laryngoscopes. TTC estimates that complications from difficult intubations generate over $5 billion in excess healthcare costs each year, underscoring the substantial unmet need for safer, more reliable tools. By offering a steerable introducer that enhances visualization and control, TTC aims to reduce procedural risk, lower complication rates, and deliver significant cost savings to healthcare systems. TTC's solution is well positioned in the growing airway management market, where video laryngoscopy is becoming standard of care. The Runnels Steerable Introducer differentiates itself through its steerable tip designed specifically to complement video laryngoscopes, potentially improving first-pass success rates and reducing trauma. While the company has not yet disclosed specific regulatory or commercial milestones, its technology addresses a clear clinical pain point with a strong value proposition. TTC's success will depend on achieving regulatory clearance (likely 510(k)), generating clinical evidence, and securing adoption by anesthesia and emergency medicine providers. With the intubation device market expected to grow steadily, TTC has the opportunity to capture share if it executes effectively on these fronts.

Upcoming Catalysts (preview)

• Q1 2027FDA 510(k) Clearance for Runnels Steerable Introducer70% success
• Q2 2027Publication of Clinical Trial Results Demonstrating Improved First-Pass Success60% success
• Q4 2026Strategic Partnership or Distribution Agreement with Major Medical Device Company50% success